Stay updated on Elotuzumab & Lenalidomide Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Elotuzumab & Lenalidomide Post-Transplant Clinical Trial page.

Latest updates to the Elotuzumab & Lenalidomide Post-Transplant Clinical Trial page
- Check5 days agoChange DetectedThe page now displays an updated “Revision” version number (from v3.5.2 to v3.5.3), indicating a software/UI release update rather than a modification to the trial’s record content.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded a new 'Study Status' entry with revision v3.5.2 dated 2026-04-15; the previous revision v3.5.0 dated 2025-10-10 was deleted.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRecord History now shows Revision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded revision v3.4.3 to the history and removed revision v3.4.2.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding operating-status notice. Core study history content and functionality remain unchanged.SummaryDifference0.5%

- Check83 days agoChange DetectedA new site-wide notice about government funding status appears, and the revision tag updates from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Elotuzumab & Lenalidomide Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elotuzumab & Lenalidomide Post-Transplant Clinical Trial page.